These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 33124154)
21. Genetic studies of multiple consanguineous Pakistani families segregating oculocutaneous albinism identified novel and reported mutations. Gul H; Shah AH; Harripaul R; Mikhailov A; Prajapati K; Khan E; Ullah F; Zubair M; Ali MZ; Shah AH; Salman S; Khan S; Vincent JB; Khan MA Ann Hum Genet; 2019 Jul; 83(4):278-284. PubMed ID: 30868578 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene. Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782 [TBL] [Abstract][Full Text] [Related]
23. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report. Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173 [TBL] [Abstract][Full Text] [Related]
25. Molecular genetic study of 59 Chinese Oculocutaneous albinism families. Luo D; Linpeng S; Zeng L; Tan H; Li Z; Wu L Eur J Med Genet; 2019 Oct; 62(10):103709. PubMed ID: 31229681 [TBL] [Abstract][Full Text] [Related]
26. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase. Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744 [TBL] [Abstract][Full Text] [Related]
27. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing. Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374 [TBL] [Abstract][Full Text] [Related]
28. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies. Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233 [TBL] [Abstract][Full Text] [Related]
29. Tyrosinase gene mutations in the Chinese Han population with OCA1. Liu N; Kong XD; Shi HR; Wu QH; Jiang M Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957 [TBL] [Abstract][Full Text] [Related]
30. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America. Urtatiz O; Sanabria D; Lattig MC J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140 [No Abstract] [Full Text] [Related]
31. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families]. Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490 [TBL] [Abstract][Full Text] [Related]
32. Identification of TYR mutations in patients with oculocutaneous albinism. Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579 [TBL] [Abstract][Full Text] [Related]
33. Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population. Jaworek TJ; Kausar T; Bell SM; Tariq N; Maqsood MI; Sohail A; Ali M; Iqbal F; Rasool S; Riazuddin S; Shaikh RS; Ahmed ZM Orphanet J Rare Dis; 2012 Jun; 7():44. PubMed ID: 22734612 [TBL] [Abstract][Full Text] [Related]
34. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics. Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663 [TBL] [Abstract][Full Text] [Related]
35. Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism. Jiang B; Zhang H; Kan Y; Gao X; Du Z; Liu Q Mol Genet Genomic Med; 2024 Jan; 12(1):e2297. PubMed ID: 37882226 [TBL] [Abstract][Full Text] [Related]
37. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations. Chen C; Li J; Wang B; Wang Y; Yu X Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795 [TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of a Chinese family with oculocutaneous albinism. Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221 [TBL] [Abstract][Full Text] [Related]
39. [Mutation analysis of two pedigrees with suspected oculocutaneous albinism]. Ye H; Lan X; Qiao T; Xu W; Tang X; Yang Y; Zhang H Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Mar; 36(3):212-216. PubMed ID: 30835348 [TBL] [Abstract][Full Text] [Related]
40. [Spectrum of pathological genetic variants among 405 Chinese pedigrees affected with oculocutaneous albinism]. Wang C; Chen C; Zhao X; Zhao G; Liu L; Kong X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jul; 37(7):725-730. PubMed ID: 32619251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]